Voisin Consulting Life Sciences post icon
Press release

Voisin Consulting Life Sciences Acquires U.S. based B&H Consulting Services, Inc.

Post thumbnail Voisin Consulting Life Sciences Acquires U.S. based B&H Consulting Services, Inc.

October 14th, 2015 – 02:00 pm
Somerville, NJ & Paris, France

Voisin Consulting Life Sciences (VCLS), the global healthcare product development consultancy, and B&H Consulting Services, Inc. (B&H), an experienced regulatory firm helping pharma and biotech companies facilitate interactions with FDA and navigate the regulatory process, today announced that they are joining forces. The transaction forms one of the largest independent consulting groups delivering high end regulatory services to support the interactions with the U.S. Food and Drug Administration, the European Medicines Agency, and other global health authorities. VCLS and B&H now have U.S. offices in Cambridge, MA; Somerville, NJ; and San Francisco, CA; in addition to Paris and Rennes, France; London, UK; Lausanne, Switzerland; Bangalore, India; and Singapore.

“The demand for U.S. regulatory strategy and operations is very high, which made us accelerate the growth of our existing U.S. teams,” says VCLS Founder and CEO Emmanuelle M. Voisin, Ph.D. “Helen Ribbans, Founder and President of B&H, and her team possess outstanding expertise, credibility in the industry, and strategic vision that make them the ideal addition to the VCLS family.”

Founded in 1988 and based in Somerville, NJ, B&H provides strategic regulatory advice to pharma and biotech companies, and supports healthcare innovators in their interactions with U.S. FDA. B&H also delivers in-depth Chemistry, Manufacturing and Controls expertise, as well as strategic and operational support for all regulatory submissions including electronic publishing services.

“We are excited by the opportunity to expand the depth and breadth of services that we can offer to our clients as they seek to meet the regulatory requirements of the global healthcare market,” said Helen M. Ribbans, B&H Founder and President.

“Joining forces with the VCLS group provides our clients with tremendous experience across all therapeutic areas, and the global footprint that they need to accelerate their results,” said Stephanie M. Pierson, who was named CEO of B&H as part of this transaction. Ms. Pierson previously was Vice-President of B&H.

The combined team now includes more than 130 regulatory science professionals located across the United States, Europe, and South-East Asia. B&H will continue to operate under its current name, management team and structure, at its Somerville, NJ, headquarters. Constantin Associates LLP, Kahn Partners LLP and Namaskar Corporate Finance acted as advisors to VCLS. Strategic Exit Advisors, Inc. and Norris McLaughlin & Marcus, P.A. acted as advisors to B&H.

About Voisin Consulting Life Sciences

Voisin Consulting Life Sciences is a global product development consultancy, which guides Biotechnology, Pharmaceutical and Medtech manufacturers throughout product development and commercialization. From discovery to patients, VCLS assists innovators to design product development strategies that optimize clinical development in order to drive commercial success, through an understanding of both regulators and payers.

VCLS team of health product specialists seamlessly supplements innovative life sciences companies’ resources with strategic advice and cross-functional operational capabilities. The firm offers integrated solutions to development planning, manufacturing, quality and controls, nonclinical and clinical testing, safety monitoring, and interactions with regulators and payers. With offices in Cambridge and San Francisco (MA & CA, USA), London (UK), Paris and Rennes (France), Lausanne (Switzerland), Bangalore (India), and Singapore, VCLS serves a broad range of developers and investors.

For more information, visit www.voisinconsulting.com

About B&H Consulting Services, Inc.

B&H Consulting Services, Inc. is a US-based regulatory consultancy, which provides regulatory affairs, electronic submission and CM&C technical writing expertise to the health sciences industry. Specialized in the planning, organization and conduct of successful Sponsor/FDA meetings, B&H represents international and US companies with FDA.

Founded in 1988 and established in Somerville, NJ, B&H professional team delivers seamless support throughout all phases of pre-marketing development and post-marketing activities.

For more information, visit www.bhconsultingservices.com


Media contacts:

LaVoie Strategic Communications Group
David Connolly, +1-617-374-8800, ext. 104 – dconnolly@lavoiegroup.com

Corporate contacts:

Nadine Ralph, +1-617-492-1537, ext. 118 – vccambridge@voisinconsulting.com
Vincent Bergeron, +33 141 318 666 – vcparis@voisinconsulting.com
Stephanie Pierson, +1-908-704-1691 – mail@bhconsultingservices.com